Covaccine is India’s indigenous vaccine. (signal picture)
A two-year-old boy to an 18-year-old has been tested at AIIMS for testing in children for the Covaxin vaccine to protect against Coronavirus in India.
New Delhi. Adolescents from two years of age to 18 years from Monday at the All India Institute of Medical Sciences (AIIMS) here for testing in children of indigenously manufactured Covaxin vaccine to protect against Coronavirus In India. The investigation started. Trial has started in Patna-based AIIMS in children to find out whether Bharat Biotech vaccines are safe for children.
Vaccines will be given to the children only after the investigation report comes. This test will be done on 525 healthy children under which the children will be given two doses of the vaccine. Of these, the second dose will be given on the 28th day after the first dose.
Dr Sanjay Rai, Professor, AIIMS’ Center for Community Medicine, said, “The screening of children has been started to test the vaccine. And only after the test report comes, the vaccine dose will be given to the children. India’s drug regulator on May 12 approved testing of Covaccine on adolescents ranging from two-year-old to 18-year-old. In the vaccination campaign in the country, adults are being vaccinated against covaccine.
The government had warnedThe government warned last week that although the coronavirus infection has not yet had a serious effect in children, its effect may increase if the virus’s behavior changes. Along with this, the government said that preparations are on to deal with any such situation. NITI Aayog member (health) VK Paul said in a press conference that a national expert group has been formed to review the infection in children and deal with it with new preparedness.
He said that this group has been examined for such symptoms, which were not there four-five months ago. This team has looked at all the things including the existing data, the dimensions of the disease, the nature of the virus and on the basis of this new guidelines have been made which will be issued soon. Paul was asked that if the Pfizer vaccine comes to India, can children between the ages of 12 and 15 be given it, as is happening in Britain? On this, Paul had said that the country has its own vaccines and they are being prepared for children.
He said, ‘The population of children is no less. According to my estimate, the number of children in the age group of 12 to 18 years is 13 to 140 million and for this we will need 25-26 crore doses of vaccine. He also said that trials of Zydus Cadila vaccines have started on children.